8-K: HeartSciences Files 2026 Annual Report, Eyes Fortitude Merger

HeartSciences Inc. announced the filing of its fiscal 2026 Form 10-K and anticipates filing a preliminary proxy statement for its proposed merger with Fortitude Mining Holdings, Inc.

Summary

• HeartSciences Inc. has filed its Annual Report on Form 10-K for the fiscal year ended April 30, 2026.
• The company is preparing to file a preliminary proxy statement with the SEC regarding its proposed business combination with Fortitude Mining Holdings, Inc.
• HeartSciences believes the merger with Fortitude, a mining platform operating in the Proof-of-Work ecosystem, presents a significant opportunity for shareholders.
• The company expects to release its fiscal 2026 earnings and a business update early next week, following the proxy statement filing.
• The MyoVista Insights AI-ECG technology is expected to continue advancing with a greater focus post-merger.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive sentiment, as it announces expected procedural filings for a merger that management believes offers significant shareholder value, but it lacks specific financial performance details and highlights inherent risks in the proposed transaction.

Positives

• Filing of the fiscal 2026 Annual Report on Form 10-K.
• Anticipated filing of a preliminary proxy statement for the proposed merger with Fortitude.
• Management views the proposed merger with Fortitude as a significant opportunity for shareholder value creation.
• The merger is expected to allow HeartSciences' MyoVista Insights AI-ECG technology to advance with greater focus.
• Fortitude is described as an institutional-scale, vertically integrated venture mining platform with a meaningful position in the Zcash network.

Negatives

• The filing does not contain detailed financial metrics for fiscal year 2026, as it primarily announces the filing of the 10-K and the upcoming proxy statement.
• The success of the proposed transaction is subject to shareholder approval and other closing conditions.
• Risks associated with the volatile nature of cryptocurrency prices (Zcash) are inherent to Fortitude's business.

Risks

• The proposed transaction may not be completed on the anticipated timeline or at all.
• Failure to satisfy the conditions to the closing of the proposed transaction, including obtaining requisite shareholder approval.
• Market or macroeconomic conditions could adversely affect HeartSciences, Fortitude, or the combined company.
• Risks related to the integration of the two companies and the management of a newly public company.
• Risks related to Fortitude's operations and business, including the highly volatile nature of the price of Zcash and other cryptocurrencies.
• Significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally.

Future Outlook

HeartSciences expects to file a preliminary proxy statement shortly and intends to issue its fiscal 2026 earnings release and a business update early next week. The company believes the proposed merger with Fortitude represents a significant opportunity for shareholder value creation and will allow its MyoVista Insights AI-ECG technology to advance with greater focus.

Management Comments

• "Fiscal 2026 was a landmark year for HeartSciences, with the launch of MyoVista Insights and the beginning of our transition to mainstream commercial revenue," said Andrew Simpson, the CEO of HeartSciences.
• "We also believe the proposed business combination with Fortitude represents a significant value creation opportunity for our shareholders."
• "The proxy statement will set out the transaction in detail, and we look forward to discussing our results, the proposed merger and the path ahead in our full earnings statement and business update early next week."

Industry Context

StockSavvy.ai notes that HeartSciences, a healthcare IT company focused on AI-ECG technology, is proposing a merger with Fortitude Mining Holdings, a venture mining platform in the Proof-of-Work ecosystem anchored in Zcash. This move suggests a strategic pivot or diversification for HeartSciences, integrating a digital asset mining operation with its healthcare technology focus, a trend that could see increased M&A activity at the intersection of technology and emerging digital asset sectors.

Stakeholder Impact

• Shareholders: Potential for value creation through the proposed merger with Fortitude, but also subject to risks associated with the transaction and Fortitude's business.
• Employees: Potential impact on roles and operations following the integration of HeartSciences and Fortitude.
• Creditors: The merger's impact on existing debt obligations for either company would be detailed in future filings.

Next Steps

• Filing of a preliminary proxy statement with the SEC.
• Issuance of fiscal 2026 earnings release and business update.
• Shareholder vote on the proposed transaction.

Key Dates

Recommendation

The filing announces procedural steps for a proposed merger and the filing of an annual report, but lacks specific financial performance data for the current period. While management expresses optimism about the merger's value creation potential, significant risks and uncertainties remain, including shareholder approval and the volatile nature of Fortitude's business. Therefore, a 'hold' recommendation is appropriate pending further details on the transaction and the combined entity's prospects.

Keywords

HeartSciences, Fortitude Mining Holdings, Merger Agreement, Proxy Statement, Form 10-K, AI-ECG, Proof-of-Work, Zcash